Correlation Between Corporate Office and CRISPR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Corporate Office and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corporate Office and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corporate Office Properties and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Corporate Office and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corporate Office with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corporate Office and CRISPR Therapeutics.
Diversification Opportunities for Corporate Office and CRISPR Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Corporate and CRISPR is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Corporate Office Properties and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Corporate Office is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corporate Office Properties are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Corporate Office i.e., Corporate Office and CRISPR Therapeutics go up and down completely randomly.
Pair Corralation between Corporate Office and CRISPR Therapeutics
If you would invest 2,263 in Corporate Office Properties on October 27, 2024 and sell it today you would earn a total of 557.00 from holding Corporate Office Properties or generate 24.61% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Corporate Office Properties vs. CRISPR Therapeutics AG
Performance |
Timeline |
Corporate Office Pro |
CRISPR Therapeutics |
Corporate Office and CRISPR Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Corporate Office and CRISPR Therapeutics
The main advantage of trading using opposite Corporate Office and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corporate Office position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.Corporate Office vs. MidCap Financial Investment | Corporate Office vs. AOYAMA TRADING | Corporate Office vs. EIDESVIK OFFSHORE NK | Corporate Office vs. Fevertree Drinks PLC |
CRISPR Therapeutics vs. UNIQA INSURANCE GR | CRISPR Therapeutics vs. National Beverage Corp | CRISPR Therapeutics vs. SAN MIGUEL BREWERY | CRISPR Therapeutics vs. S E BANKEN A |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |